Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gene Editing | 28 | 2025 | 289 | 5.750 |
Why?
|
CRISPR-Cas Systems | 26 | 2025 | 325 | 3.840 |
Why?
|
Zebrafish | 18 | 2023 | 323 | 3.380 |
Why?
|
Zinc Fingers | 15 | 2015 | 95 | 3.300 |
Why?
|
Gene Targeting | 9 | 2020 | 82 | 1.950 |
Why?
|
Endonucleases | 8 | 2022 | 81 | 1.810 |
Why?
|
DNA | 21 | 2023 | 793 | 1.760 |
Why?
|
Nerve Transfer | 3 | 2015 | 6 | 1.510 |
Why?
|
Brachial Plexus | 3 | 2015 | 6 | 1.500 |
Why?
|
Base Sequence | 19 | 2022 | 1312 | 1.490 |
Why?
|
Transcription Factors | 19 | 2022 | 1456 | 1.450 |
Why?
|
Hematopoietic Stem Cells | 10 | 2024 | 275 | 1.350 |
Why?
|
Two-Hybrid System Techniques | 8 | 2011 | 65 | 1.350 |
Why?
|
Deoxyribonucleases | 5 | 2017 | 30 | 1.300 |
Why?
|
Genome | 5 | 2023 | 253 | 1.260 |
Why?
|
Clustered Regularly Interspaced Short Palindromic Repeats | 5 | 2019 | 85 | 1.240 |
Why?
|
CRISPR-Associated Proteins | 3 | 2019 | 31 | 1.240 |
Why?
|
Binding Sites | 18 | 2023 | 875 | 1.220 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 3 | 2013 | 26 | 1.170 |
Why?
|
Zebrafish Proteins | 9 | 2019 | 150 | 1.160 |
Why?
|
Protein Engineering | 7 | 2019 | 77 | 1.150 |
Why?
|
Animals | 68 | 2025 | 19608 | 1.130 |
Why?
|
Ribonucleoproteins | 4 | 2025 | 112 | 1.070 |
Why?
|
Homeodomain Proteins | 6 | 2019 | 254 | 1.050 |
Why?
|
Drosophila Proteins | 6 | 2013 | 681 | 1.010 |
Why?
|
DNA Breaks, Double-Stranded | 4 | 2023 | 77 | 1.000 |
Why?
|
Peripheral Nerves | 2 | 2015 | 28 | 0.970 |
Why?
|
Microsurgery | 2 | 2015 | 52 | 0.960 |
Why?
|
Radial Nerve | 1 | 2024 | 2 | 0.940 |
Why?
|
Nerve Compression Syndromes | 1 | 2024 | 10 | 0.930 |
Why?
|
DNA-Binding Proteins | 9 | 2015 | 1128 | 0.920 |
Why?
|
Regulatory Elements, Transcriptional | 5 | 2015 | 36 | 0.870 |
Why?
|
Fetal Hemoglobin | 6 | 2024 | 12 | 0.870 |
Why?
|
Terminology as Topic | 1 | 2024 | 138 | 0.860 |
Why?
|
Cold Temperature | 1 | 2023 | 51 | 0.850 |
Why?
|
HEK293 Cells | 9 | 2025 | 577 | 0.790 |
Why?
|
DNA, Single-Stranded | 1 | 2022 | 100 | 0.760 |
Why?
|
Software | 7 | 2023 | 367 | 0.740 |
Why?
|
Sequence Analysis, DNA | 5 | 2018 | 396 | 0.740 |
Why?
|
Databases, Genetic | 3 | 2017 | 82 | 0.730 |
Why?
|
Repressor Proteins | 8 | 2024 | 336 | 0.710 |
Why?
|
Chromosome Inversion | 3 | 2024 | 18 | 0.700 |
Why?
|
DNA End-Joining Repair | 2 | 2019 | 24 | 0.670 |
Why?
|
Sequence Deletion | 2 | 2019 | 114 | 0.660 |
Why?
|
Connectin | 1 | 2019 | 10 | 0.650 |
Why?
|
Hermanski-Pudlak Syndrome | 1 | 2019 | 7 | 0.650 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 1 | 2019 | 10 | 0.650 |
Why?
|
Mutant Chimeric Proteins | 1 | 2018 | 6 | 0.640 |
Why?
|
Mice | 33 | 2025 | 10254 | 0.630 |
Why?
|
Nucleotide Motifs | 4 | 2018 | 44 | 0.620 |
Why?
|
Humans | 55 | 2025 | 59303 | 0.610 |
Why?
|
Drosophila melanogaster | 5 | 2015 | 480 | 0.600 |
Why?
|
Drosophila | 5 | 2013 | 419 | 0.580 |
Why?
|
Animals, Genetically Modified | 6 | 2022 | 281 | 0.570 |
Why?
|
INDEL Mutation | 3 | 2022 | 18 | 0.550 |
Why?
|
Statistics as Topic | 1 | 2017 | 147 | 0.540 |
Why?
|
Bacterial Proteins | 4 | 2019 | 749 | 0.530 |
Why?
|
Hematopoietic Stem Cell Transplantation | 7 | 2024 | 330 | 0.530 |
Why?
|
K562 Cells | 3 | 2022 | 58 | 0.530 |
Why?
|
Brachial Plexus Neuropathies | 1 | 2015 | 3 | 0.520 |
Why?
|
Elbow Joint | 1 | 2015 | 12 | 0.520 |
Why?
|
Shoulder Joint | 1 | 2015 | 22 | 0.510 |
Why?
|
Synovitis, Pigmented Villonodular | 1 | 2015 | 3 | 0.490 |
Why?
|
Giant Cell Tumors | 1 | 2015 | 5 | 0.490 |
Why?
|
Body Patterning | 4 | 2011 | 85 | 0.480 |
Why?
|
Mutagenesis | 4 | 2021 | 129 | 0.470 |
Why?
|
Gene Expression Regulation | 10 | 2021 | 1537 | 0.460 |
Why?
|
Genetic Engineering | 3 | 2018 | 112 | 0.460 |
Why?
|
Genome, Human | 4 | 2021 | 219 | 0.450 |
Why?
|
Protein Binding | 12 | 2021 | 1550 | 0.450 |
Why?
|
Mammals | 3 | 2023 | 204 | 0.430 |
Why?
|
Bacteria | 6 | 2011 | 276 | 0.430 |
Why?
|
Chromosome Deletion | 1 | 2013 | 41 | 0.420 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 301 | 0.420 |
Why?
|
gamma-Globins | 3 | 2020 | 4 | 0.390 |
Why?
|
Developmental Biology | 1 | 2011 | 6 | 0.380 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2024 | 54 | 0.380 |
Why?
|
Genetic Techniques | 1 | 2011 | 40 | 0.370 |
Why?
|
Signal Transduction | 6 | 2024 | 2890 | 0.360 |
Why?
|
Alleles | 6 | 2023 | 425 | 0.360 |
Why?
|
Jurkat Cells | 3 | 2019 | 102 | 0.350 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 2 | 2021 | 17 | 0.350 |
Why?
|
Computational Biology | 5 | 2013 | 325 | 0.340 |
Why?
|
Range of Motion, Articular | 3 | 2015 | 82 | 0.340 |
Why?
|
Molecular Sequence Data | 9 | 2014 | 1977 | 0.330 |
Why?
|
Tyrosinemias | 2 | 2021 | 19 | 0.320 |
Why?
|
Tendons | 1 | 2008 | 20 | 0.310 |
Why?
|
Escherichia coli | 3 | 2014 | 685 | 0.310 |
Why?
|
Tendon Injuries | 1 | 2008 | 16 | 0.310 |
Why?
|
Cell Line | 4 | 2023 | 2014 | 0.310 |
Why?
|
Embryonic Development | 4 | 2013 | 136 | 0.310 |
Why?
|
Cell Proliferation | 3 | 2024 | 944 | 0.300 |
Why?
|
Orthopedic Procedures | 1 | 2008 | 43 | 0.300 |
Why?
|
Anemia, Sickle Cell | 4 | 2024 | 66 | 0.300 |
Why?
|
Neurofibromatosis 1 | 2 | 2022 | 28 | 0.300 |
Why?
|
Knee Injuries | 1 | 2008 | 47 | 0.300 |
Why?
|
Gene Regulatory Networks | 3 | 2015 | 139 | 0.300 |
Why?
|
Neisseria meningitidis | 2 | 2018 | 104 | 0.290 |
Why?
|
Transfection | 3 | 2021 | 673 | 0.290 |
Why?
|
Chromatin | 4 | 2023 | 594 | 0.290 |
Why?
|
Amino Acid Sequence | 9 | 2019 | 1582 | 0.270 |
Why?
|
Enhancer Elements, Genetic | 5 | 2024 | 101 | 0.270 |
Why?
|
Embryo, Nonmammalian | 5 | 2019 | 170 | 0.270 |
Why?
|
Macaca mulatta | 2 | 2024 | 247 | 0.260 |
Why?
|
Orotidine-5'-Phosphate Decarboxylase | 1 | 2006 | 1 | 0.260 |
Why?
|
Mutation | 8 | 2022 | 2427 | 0.260 |
Why?
|
Genetic Markers | 1 | 2006 | 121 | 0.260 |
Why?
|
Sequence Analysis | 1 | 2005 | 12 | 0.250 |
Why?
|
Gene Silencing | 1 | 2008 | 377 | 0.250 |
Why?
|
Selection, Genetic | 1 | 2006 | 68 | 0.250 |
Why?
|
Amino Acid Motifs | 2 | 2012 | 152 | 0.250 |
Why?
|
beta-Thalassemia | 3 | 2020 | 13 | 0.240 |
Why?
|
Protein Interaction Mapping | 1 | 2005 | 71 | 0.240 |
Why?
|
Leukocyte Common Antigens | 1 | 2024 | 55 | 0.240 |
Why?
|
Cytosine | 1 | 2025 | 30 | 0.240 |
Why?
|
Neuropilin-1 | 1 | 2024 | 12 | 0.240 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2024 | 163 | 0.240 |
Why?
|
Radial Neuropathy | 1 | 2024 | 3 | 0.240 |
Why?
|
Proprotein Convertase 9 | 2 | 2022 | 12 | 0.230 |
Why?
|
Neurofibromin 1 | 2 | 2022 | 11 | 0.230 |
Why?
|
Thermogenesis | 2 | 2023 | 108 | 0.230 |
Why?
|
Recombinant Fusion Proteins | 3 | 2013 | 502 | 0.230 |
Why?
|
DNA, Bacterial | 1 | 2005 | 260 | 0.230 |
Why?
|
Transcriptional Activation | 2 | 2015 | 188 | 0.220 |
Why?
|
Blood Platelet Disorders | 1 | 2023 | 11 | 0.220 |
Why?
|
Genomics | 4 | 2018 | 314 | 0.220 |
Why?
|
Cold-Shock Response | 1 | 2023 | 3 | 0.220 |
Why?
|
Gene Expression Regulation, Developmental | 8 | 2019 | 630 | 0.220 |
Why?
|
Cell Line, Tumor | 7 | 2024 | 1370 | 0.220 |
Why?
|
Integrases | 1 | 2023 | 36 | 0.220 |
Why?
|
Plasmids | 2 | 2019 | 282 | 0.210 |
Why?
|
Erythroid Cells | 2 | 2021 | 10 | 0.210 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 47 | 0.210 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2024 | 201 | 0.210 |
Why?
|
Genetic Vectors | 4 | 2021 | 813 | 0.210 |
Why?
|
Penicillins | 5 | 1999 | 28 | 0.210 |
Why?
|
Nucleic Acid Conformation | 3 | 2019 | 231 | 0.200 |
Why?
|
Genes, Reporter | 4 | 2022 | 243 | 0.200 |
Why?
|
ATP-Dependent Proteases | 1 | 2022 | 7 | 0.200 |
Why?
|
Oxidative Phosphorylation | 1 | 2022 | 34 | 0.200 |
Why?
|
Protein Structure, Tertiary | 3 | 2010 | 663 | 0.200 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2021 | 27 | 0.190 |
Why?
|
Mucopolysaccharidosis II | 1 | 2021 | 11 | 0.190 |
Why?
|
Substrate Specificity | 3 | 2014 | 321 | 0.190 |
Why?
|
Recombinational DNA Repair | 1 | 2021 | 20 | 0.190 |
Why?
|
DNA, Mitochondrial | 1 | 2022 | 76 | 0.190 |
Why?
|
Adipocytes, Brown | 1 | 2021 | 45 | 0.190 |
Why?
|
HeLa Cells | 2 | 2021 | 527 | 0.190 |
Why?
|
Mitochondrial Proteins | 1 | 2022 | 99 | 0.190 |
Why?
|
Leukocyte Elastase | 1 | 2021 | 12 | 0.180 |
Why?
|
Carrier Proteins | 3 | 2025 | 710 | 0.180 |
Why?
|
Adipocytes | 1 | 2023 | 252 | 0.180 |
Why?
|
Gene Transfer Techniques | 3 | 2019 | 304 | 0.180 |
Why?
|
Recovery of Function | 2 | 2015 | 262 | 0.180 |
Why?
|
Cells | 1 | 2021 | 30 | 0.180 |
Why?
|
Cells, Cultured | 3 | 2021 | 2103 | 0.180 |
Why?
|
Glucose Intolerance | 1 | 2021 | 88 | 0.180 |
Why?
|
Algorithms | 3 | 2023 | 986 | 0.180 |
Why?
|
Neutropenia | 1 | 2021 | 66 | 0.180 |
Why?
|
Liver | 3 | 2022 | 784 | 0.180 |
Why?
|
Models, Molecular | 3 | 2013 | 1125 | 0.180 |
Why?
|
Dyskeratosis Congenita | 1 | 2020 | 3 | 0.180 |
Why?
|
Nervous System Diseases | 1 | 2021 | 95 | 0.180 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2021 | 113 | 0.180 |
Why?
|
Telomerase | 1 | 2020 | 30 | 0.170 |
Why?
|
Huntington Disease | 1 | 2022 | 146 | 0.170 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2012 | 255 | 0.170 |
Why?
|
Nuclear Proteins | 4 | 2019 | 759 | 0.170 |
Why?
|
Carcinogenesis | 1 | 2021 | 116 | 0.170 |
Why?
|
DNA Replication | 1 | 2022 | 229 | 0.170 |
Why?
|
Chemokines | 2 | 2011 | 94 | 0.170 |
Why?
|
Phylogeny | 2 | 2013 | 331 | 0.170 |
Why?
|
Streptomyces | 6 | 1999 | 19 | 0.170 |
Why?
|
Cell Differentiation | 6 | 2021 | 1295 | 0.170 |
Why?
|
Genetic Therapy | 3 | 2021 | 734 | 0.170 |
Why?
|
DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2019 | 15 | 0.160 |
Why?
|
Nuclear Localization Signals | 1 | 2019 | 18 | 0.160 |
Why?
|
Inverted Repeat Sequences | 1 | 2019 | 14 | 0.160 |
Why?
|
beta-Globins | 1 | 2019 | 9 | 0.160 |
Why?
|
Frameshift Mutation | 1 | 2019 | 28 | 0.160 |
Why?
|
Poly (ADP-Ribose) Polymerase-1 | 1 | 2019 | 17 | 0.160 |
Why?
|
Models, Biological | 6 | 2019 | 1139 | 0.160 |
Why?
|
Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 19 | 0.160 |
Why?
|
Lymphatic Vessels | 1 | 2019 | 31 | 0.160 |
Why?
|
RNA Splice Sites | 1 | 2019 | 22 | 0.160 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2019 | 75 | 0.160 |
Why?
|
GATA2 Transcription Factor | 2 | 2024 | 12 | 0.160 |
Why?
|
Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 2018 | 14 | 0.160 |
Why?
|
Mitochondria | 1 | 2022 | 333 | 0.160 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 135 | 0.150 |
Why?
|
Gene Library | 3 | 2011 | 99 | 0.150 |
Why?
|
Genes, Neurofibromatosis 1 | 2 | 2022 | 9 | 0.150 |
Why?
|
Proteins | 1 | 2004 | 742 | 0.150 |
Why?
|
Myoblasts | 1 | 2019 | 63 | 0.150 |
Why?
|
Dependovirus | 2 | 2021 | 655 | 0.150 |
Why?
|
DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2018 | 25 | 0.150 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 3 | 2024 | 86 | 0.150 |
Why?
|
Heterochromatin | 1 | 2018 | 84 | 0.150 |
Why?
|
Chromosome Mapping | 2 | 2018 | 294 | 0.150 |
Why?
|
Carpal Bones | 1 | 1997 | 3 | 0.150 |
Why?
|
Wrist Joint | 1 | 1997 | 7 | 0.150 |
Why?
|
HIV-1 | 1 | 2023 | 707 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 99 | 0.150 |
Why?
|
RNA Splicing | 1 | 2019 | 161 | 0.140 |
Why?
|
Staphylococcus aureus | 1 | 2018 | 158 | 0.140 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2022 | 396 | 0.140 |
Why?
|
Obesity | 2 | 2023 | 1189 | 0.140 |
Why?
|
Nucleotides | 2 | 2018 | 42 | 0.140 |
Why?
|
Heterografts | 3 | 2024 | 60 | 0.140 |
Why?
|
Gene Order | 2 | 2016 | 29 | 0.140 |
Why?
|
Molecular Sequence Annotation | 1 | 2017 | 59 | 0.140 |
Why?
|
Transcription Activator-Like Effector Nucleases | 1 | 2016 | 4 | 0.130 |
Why?
|
Proteomics | 1 | 2018 | 252 | 0.130 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 183 | 0.130 |
Why?
|
HIV Infections | 1 | 2023 | 919 | 0.130 |
Why?
|
Sensitivity and Specificity | 3 | 2006 | 1093 | 0.130 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2017 | 158 | 0.130 |
Why?
|
Transformation, Bacterial | 2 | 2006 | 12 | 0.130 |
Why?
|
RNA Editing | 1 | 2016 | 21 | 0.130 |
Why?
|
DNA Cleavage | 1 | 2015 | 18 | 0.130 |
Why?
|
Muscle Strength | 1 | 2015 | 37 | 0.130 |
Why?
|
Electromyography | 1 | 2015 | 87 | 0.130 |
Why?
|
Adult | 5 | 2021 | 15729 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 1454 | 0.130 |
Why?
|
Evolution, Molecular | 1 | 2018 | 291 | 0.130 |
Why?
|
Cephalosporins | 5 | 1999 | 16 | 0.120 |
Why?
|
Sequence Alignment | 2 | 2013 | 290 | 0.120 |
Why?
|
Disease Models, Animal | 5 | 2021 | 2062 | 0.120 |
Why?
|
Caenorhabditis elegans | 1 | 2022 | 617 | 0.120 |
Why?
|
Insect Proteins | 2 | 2012 | 79 | 0.120 |
Why?
|
Finger Joint | 1 | 2015 | 7 | 0.120 |
Why?
|
Arm | 1 | 2014 | 38 | 0.120 |
Why?
|
Ankle Joint | 1 | 2015 | 36 | 0.120 |
Why?
|
Treatment Outcome | 2 | 2015 | 5141 | 0.120 |
Why?
|
Morpholinos | 1 | 2014 | 50 | 0.120 |
Why?
|
Rare Diseases | 1 | 2015 | 37 | 0.120 |
Why?
|
Chromosomes, Human | 1 | 2015 | 54 | 0.120 |
Why?
|
Biopsy, Needle | 1 | 2015 | 126 | 0.120 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 193 | 0.110 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 242 | 0.110 |
Why?
|
Suture Techniques | 1 | 2014 | 84 | 0.110 |
Why?
|
Neovascularization, Physiologic | 2 | 2011 | 102 | 0.110 |
Why?
|
Promoter Regions, Genetic | 4 | 2019 | 659 | 0.110 |
Why?
|
Saccharomyces cerevisiae | 1 | 2018 | 529 | 0.110 |
Why?
|
Germ-Line Mutation | 3 | 2023 | 47 | 0.110 |
Why?
|
Neoplasms | 2 | 2021 | 1234 | 0.110 |
Why?
|
Neoplasm Staging | 1 | 2015 | 450 | 0.110 |
Why?
|
Disability Evaluation | 1 | 2014 | 214 | 0.110 |
Why?
|
Erythropoiesis | 3 | 2021 | 35 | 0.110 |
Why?
|
Oligonucleotides, Antisense | 1 | 2014 | 133 | 0.110 |
Why?
|
Pluripotent Stem Cells | 1 | 2014 | 67 | 0.110 |
Why?
|
Chromosome Breakpoints | 1 | 2013 | 5 | 0.110 |
Why?
|
Artificial Intelligence | 2 | 2014 | 166 | 0.110 |
Why?
|
Position-Specific Scoring Matrices | 1 | 2013 | 7 | 0.110 |
Why?
|
DNA Primers | 1 | 2014 | 291 | 0.110 |
Why?
|
Radiography | 1 | 2015 | 505 | 0.110 |
Why?
|
Recurrence | 1 | 2015 | 576 | 0.110 |
Why?
|
Apoptosis | 1 | 2018 | 1038 | 0.100 |
Why?
|
Stem Cells | 2 | 2012 | 257 | 0.100 |
Why?
|
Immunohistochemistry | 1 | 2015 | 846 | 0.100 |
Why?
|
Oxidoreductases | 4 | 1988 | 65 | 0.100 |
Why?
|
Response Elements | 1 | 2012 | 42 | 0.100 |
Why?
|
Antigens, CD34 | 2 | 2024 | 53 | 0.100 |
Why?
|
Butterflies | 1 | 2012 | 30 | 0.100 |
Why?
|
Germ Cells | 1 | 2013 | 97 | 0.100 |
Why?
|
Cluster Analysis | 1 | 2013 | 250 | 0.100 |
Why?
|
Alternative Splicing | 1 | 2013 | 120 | 0.100 |
Why?
|
Endodeoxyribonucleases | 1 | 2012 | 40 | 0.100 |
Why?
|
Muscle Proteins | 1 | 2012 | 109 | 0.100 |
Why?
|
Molecular Docking Simulation | 1 | 2012 | 79 | 0.100 |
Why?
|
Chemokine CXCL12 | 1 | 2011 | 15 | 0.100 |
Why?
|
Patient Satisfaction | 1 | 2014 | 413 | 0.090 |
Why?
|
Catalytic Domain | 1 | 2012 | 184 | 0.090 |
Why?
|
Penicillin-Binding Proteins | 4 | 1998 | 9 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 192 | 0.090 |
Why?
|
Cell Biology | 1 | 2011 | 21 | 0.090 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 75 | 0.090 |
Why?
|
Veins | 1 | 2011 | 61 | 0.090 |
Why?
|
Bone Marrow Cells | 1 | 2011 | 231 | 0.090 |
Why?
|
Arteries | 1 | 2011 | 74 | 0.090 |
Why?
|
Hyperglycemia | 1 | 2011 | 103 | 0.090 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2010 | 14 | 0.090 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2011 | 195 | 0.090 |
Why?
|
Protein Conformation | 1 | 2013 | 766 | 0.090 |
Why?
|
Hemodynamics | 1 | 2011 | 232 | 0.080 |
Why?
|
Cohort Studies | 1 | 2015 | 2435 | 0.080 |
Why?
|
Oligopeptides | 3 | 1989 | 134 | 0.080 |
Why?
|
Oligonucleotides | 2 | 2024 | 208 | 0.080 |
Why?
|
Enzymes | 4 | 1988 | 32 | 0.080 |
Why?
|
Penicillin G | 2 | 1999 | 5 | 0.080 |
Why?
|
Follow-Up Studies | 1 | 2015 | 2323 | 0.080 |
Why?
|
Male | 5 | 2021 | 27480 | 0.080 |
Why?
|
Female | 6 | 2021 | 30798 | 0.080 |
Why?
|
Genes, Bacterial | 2 | 2006 | 117 | 0.080 |
Why?
|
Aorta | 1 | 2009 | 103 | 0.080 |
Why?
|
RNA | 2 | 2024 | 404 | 0.080 |
Why?
|
Genome, Insect | 1 | 2008 | 31 | 0.080 |
Why?
|
Mice, Knockout | 3 | 2023 | 1988 | 0.080 |
Why?
|
Postoperative Complications | 1 | 2014 | 1127 | 0.080 |
Why?
|
Transplantation, Homologous | 1 | 2008 | 231 | 0.070 |
Why?
|
Risk Assessment | 1 | 2015 | 1907 | 0.070 |
Why?
|
Point Mutation | 2 | 2019 | 162 | 0.070 |
Why?
|
Quality of Life | 1 | 2014 | 1108 | 0.070 |
Why?
|
Conserved Sequence | 1 | 2008 | 171 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2012 | 673 | 0.070 |
Why?
|
Insulin | 1 | 2011 | 687 | 0.070 |
Why?
|
Green Fluorescent Proteins | 2 | 2019 | 353 | 0.070 |
Why?
|
Orotic Acid | 1 | 2006 | 1 | 0.070 |
Why?
|
Larva | 2 | 2019 | 127 | 0.070 |
Why?
|
Mice, Transgenic | 2 | 2020 | 1221 | 0.070 |
Why?
|
Aged, 80 and over | 1 | 2015 | 5063 | 0.060 |
Why?
|
Young Adult | 1 | 2015 | 4318 | 0.060 |
Why?
|
Mutagenesis, Insertional | 1 | 2006 | 92 | 0.060 |
Why?
|
Intramolecular Transferases | 4 | 1998 | 4 | 0.060 |
Why?
|
Genes, Regulator | 1 | 2005 | 27 | 0.060 |
Why?
|
Computer Simulation | 2 | 2023 | 454 | 0.060 |
Why?
|
Acremonium | 5 | 1988 | 5 | 0.060 |
Why?
|
Morphogenesis | 2 | 2019 | 112 | 0.060 |
Why?
|
Transcriptional Regulator ERG | 1 | 2024 | 4 | 0.060 |
Why?
|
Adolescent | 1 | 2015 | 5914 | 0.060 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2024 | 26 | 0.060 |
Why?
|
Core Binding Factor beta Subunit | 1 | 2024 | 24 | 0.060 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2024 | 50 | 0.060 |
Why?
|
Recombination, Genetic | 1 | 2006 | 236 | 0.060 |
Why?
|
Mice, Inbred C57BL | 3 | 2018 | 3187 | 0.060 |
Why?
|
Gene Deletion | 1 | 2006 | 298 | 0.060 |
Why?
|
Transplantation Conditioning | 1 | 2024 | 94 | 0.060 |
Why?
|
Immunoconjugates | 1 | 2024 | 84 | 0.060 |
Why?
|
Electroporation | 1 | 2024 | 32 | 0.060 |
Why?
|
Leucine Zippers | 1 | 2003 | 12 | 0.060 |
Why?
|
MicroRNAs | 1 | 2010 | 617 | 0.060 |
Why?
|
Peptide Library | 1 | 2003 | 35 | 0.060 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2004 | 357 | 0.060 |
Why?
|
Dimerization | 1 | 2003 | 146 | 0.050 |
Why?
|
Tissue Distribution | 1 | 2024 | 282 | 0.050 |
Why?
|
Mice, Obese | 1 | 2023 | 79 | 0.050 |
Why?
|
Disease Susceptibility | 1 | 2023 | 158 | 0.050 |
Why?
|
Gene Knockout Techniques | 1 | 2023 | 89 | 0.050 |
Why?
|
Neurons | 2 | 2022 | 858 | 0.050 |
Why?
|
Interleukin-2 | 1 | 2023 | 164 | 0.050 |
Why?
|
Gene Expression | 1 | 2006 | 808 | 0.050 |
Why?
|
Brain | 1 | 2011 | 1487 | 0.050 |
Why?
|
Crystallography, X-Ray | 1 | 2003 | 422 | 0.050 |
Why?
|
Lymphocytes | 1 | 2023 | 194 | 0.050 |
Why?
|
Codon | 1 | 2022 | 47 | 0.050 |
Why?
|
DNA Polymerase gamma | 1 | 2022 | 4 | 0.050 |
Why?
|
Codon, Nonsense | 1 | 2022 | 51 | 0.050 |
Why?
|
Ribonuclease H | 1 | 2022 | 18 | 0.050 |
Why?
|
Biotinylation | 1 | 2022 | 38 | 0.050 |
Why?
|
Cell Survival | 1 | 2024 | 553 | 0.050 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2022 | 22 | 0.050 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 214 | 0.050 |
Why?
|
Biotin | 1 | 2022 | 52 | 0.050 |
Why?
|
Transcription, Genetic | 2 | 2018 | 847 | 0.050 |
Why?
|
Histones | 2 | 2018 | 463 | 0.050 |
Why?
|
Adipocytes, White | 1 | 2021 | 27 | 0.050 |
Why?
|
Adult Stem Cells | 1 | 2021 | 28 | 0.050 |
Why?
|
Subcutaneous Fat | 1 | 2021 | 50 | 0.050 |
Why?
|
Huntingtin Protein | 1 | 2022 | 138 | 0.050 |
Why?
|
Peptide Synthases | 2 | 1992 | 3 | 0.050 |
Why?
|
Proteolysis | 1 | 2022 | 138 | 0.050 |
Why?
|
Hematopoiesis | 1 | 2021 | 123 | 0.050 |
Why?
|
Fatty Liver | 1 | 2021 | 97 | 0.050 |
Why?
|
Nanoparticles | 2 | 2017 | 496 | 0.050 |
Why?
|
Diet, High-Fat | 1 | 2021 | 159 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 117 | 0.040 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 177 | 0.040 |
Why?
|
Virulence | 1 | 2021 | 189 | 0.040 |
Why?
|
Receptors, CXCR4 | 2 | 2011 | 32 | 0.040 |
Why?
|
Goals | 1 | 2021 | 89 | 0.040 |
Why?
|
Aged | 1 | 2015 | 13285 | 0.040 |
Why?
|
Primary Cell Culture | 1 | 2020 | 75 | 0.040 |
Why?
|
Telomere | 1 | 2020 | 47 | 0.040 |
Why?
|
Lipid Metabolism | 1 | 2021 | 200 | 0.040 |
Why?
|
Hemoglobinopathies | 1 | 2019 | 5 | 0.040 |
Why?
|
Alcohols | 1 | 1999 | 13 | 0.040 |
Why?
|
Endothelial Progenitor Cells | 1 | 2019 | 8 | 0.040 |
Why?
|
Face | 1 | 2019 | 34 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2019 | 191 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2022 | 462 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2023 | 636 | 0.040 |
Why?
|
APOBEC Deaminases | 1 | 2019 | 7 | 0.040 |
Why?
|
Cytokines | 1 | 2023 | 906 | 0.040 |
Why?
|
Adenosine Deaminase | 1 | 2019 | 16 | 0.040 |
Why?
|
Erythroid Precursor Cells | 1 | 2019 | 20 | 0.040 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2019 | 83 | 0.040 |
Why?
|
Middle Aged | 1 | 2015 | 16231 | 0.040 |
Why?
|
Isoenzymes | 1 | 2019 | 134 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 515 | 0.040 |
Why?
|
Azepines | 1 | 2018 | 19 | 0.040 |
Why?
|
Polycomb Repressive Complex 1 | 1 | 2018 | 31 | 0.040 |
Why?
|
Multifunctional Enzymes | 1 | 2018 | 17 | 0.040 |
Why?
|
Triazoles | 1 | 2018 | 55 | 0.040 |
Why?
|
Artifacts | 1 | 2019 | 126 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2014 | 1470 | 0.040 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2018 | 123 | 0.040 |
Why?
|
Benzimidazoles | 1 | 2018 | 59 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2020 | 522 | 0.040 |
Why?
|
Critical Care | 1 | 2021 | 406 | 0.040 |
Why?
|
Wrist Injuries | 1 | 1997 | 11 | 0.040 |
Why?
|
Joint Dislocations | 1 | 1997 | 15 | 0.040 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2017 | 32 | 0.040 |
Why?
|
beta-Transducin Repeat-Containing Proteins | 1 | 2017 | 5 | 0.040 |
Why?
|
Cell Separation | 1 | 2018 | 149 | 0.040 |
Why?
|
Fluoroscopy | 1 | 1997 | 58 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2019 | 265 | 0.040 |
Why?
|
Leukemia | 1 | 2017 | 53 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2023 | 766 | 0.040 |
Why?
|
Oncogenes | 1 | 2017 | 68 | 0.040 |
Why?
|
Proteome | 1 | 2018 | 135 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 387 | 0.040 |
Why?
|
beta Catenin | 1 | 2017 | 85 | 0.040 |
Why?
|
Lung | 1 | 2022 | 823 | 0.040 |
Why?
|
Inflammation | 1 | 2023 | 1101 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 1997 | 76 | 0.030 |
Why?
|
Wnt Proteins | 1 | 2017 | 91 | 0.030 |
Why?
|
Reference Values | 1 | 1997 | 323 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2018 | 156 | 0.030 |
Why?
|
DNA Helicases | 1 | 2018 | 187 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2021 | 1546 | 0.030 |
Why?
|
Escherichia coli Proteins | 1 | 2019 | 260 | 0.030 |
Why?
|
Cytoplasm | 1 | 2017 | 273 | 0.030 |
Why?
|
Chickens | 1 | 2016 | 91 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 569 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2018 | 671 | 0.030 |
Why?
|
Rats | 2 | 2017 | 1907 | 0.030 |
Why?
|
Viruses | 1 | 2016 | 79 | 0.030 |
Why?
|
Rhombencephalon | 1 | 2014 | 7 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2014 | 192 | 0.030 |
Why?
|
Tretinoin | 1 | 2014 | 48 | 0.030 |
Why?
|
SOXF Transcription Factors | 1 | 2014 | 10 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2014 | 16 | 0.030 |
Why?
|
Anti-Bacterial Agents | 3 | 1984 | 721 | 0.030 |
Why?
|
Lipids | 1 | 2016 | 305 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 525 | 0.030 |
Why?
|
Blotting, Western | 1 | 2014 | 595 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 397 | 0.030 |
Why?
|
Genes | 2 | 1990 | 96 | 0.030 |
Why?
|
SOXD Transcription Factors | 1 | 2012 | 5 | 0.030 |
Why?
|
Embryonic Stem Cells | 1 | 2014 | 150 | 0.030 |
Why?
|
Cell Lineage | 1 | 2014 | 250 | 0.030 |
Why?
|
Melanophores | 1 | 2012 | 2 | 0.030 |
Why?
|
Schwann Cells | 1 | 2012 | 7 | 0.030 |
Why?
|
Nucleosomes | 1 | 2014 | 185 | 0.030 |
Why?
|
Oligodendroglia | 1 | 2012 | 33 | 0.030 |
Why?
|
Cryptochromes | 1 | 2012 | 42 | 0.030 |
Why?
|
Support Vector Machine | 1 | 2012 | 22 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2012 | 96 | 0.030 |
Why?
|
Myelin Sheath | 1 | 2012 | 35 | 0.030 |
Why?
|
Hyperplasia | 1 | 2012 | 85 | 0.030 |
Why?
|
ras Proteins | 1 | 2012 | 78 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 643 | 0.020 |
Why?
|
Circadian Clocks | 1 | 2012 | 44 | 0.020 |
Why?
|
Mixed Function Oxygenases | 1 | 1991 | 17 | 0.020 |
Why?
|
Exons | 1 | 2012 | 193 | 0.020 |
Why?
|
C-Peptide | 1 | 2011 | 23 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 1999 | 198 | 0.020 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2013 | 229 | 0.020 |
Why?
|
Chemokines, CXC | 1 | 2011 | 27 | 0.020 |
Why?
|
Up-Regulation | 1 | 2012 | 363 | 0.020 |
Why?
|
Organ Specificity | 1 | 2011 | 178 | 0.020 |
Why?
|
Phenotype | 1 | 2014 | 1155 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2010 | 694 | 0.020 |
Why?
|
Learning | 1 | 2012 | 171 | 0.020 |
Why?
|
Models, Statistical | 1 | 2012 | 306 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 1990 | 27 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2012 | 299 | 0.020 |
Why?
|
Biocatalysis | 1 | 2010 | 46 | 0.020 |
Why?
|
Ribonuclease III | 1 | 2010 | 81 | 0.020 |
Why?
|
Survival Analysis | 1 | 2011 | 553 | 0.020 |
Why?
|
Pregnancy | 1 | 2017 | 2352 | 0.020 |
Why?
|
Insulin-Secreting Cells | 1 | 2011 | 177 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2010 | 129 | 0.020 |
Why?
|
RNA Precursors | 1 | 2010 | 74 | 0.020 |
Why?
|
Body Weight | 1 | 2011 | 378 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2011 | 250 | 0.020 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2010 | 87 | 0.020 |
Why?
|
Motor Activity | 1 | 2012 | 342 | 0.020 |
Why?
|
Models, Genetic | 1 | 2010 | 253 | 0.020 |
Why?
|
Osteoblasts | 1 | 1990 | 204 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1991 | 182 | 0.020 |
Why?
|
Streptococcus | 1 | 1989 | 17 | 0.020 |
Why?
|
Argonaute Proteins | 1 | 2010 | 129 | 0.020 |
Why?
|
Kinetics | 3 | 1998 | 733 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2009 | 177 | 0.020 |
Why?
|
United States | 1 | 2021 | 7492 | 0.020 |
Why?
|
Cyclization | 1 | 1986 | 2 | 0.020 |
Why?
|
Magnesium Compounds | 1 | 1984 | 2 | 0.010 |
Why?
|
Nitrogen | 1 | 1984 | 24 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1984 | 65 | 0.010 |
Why?
|
Adenosine Triphosphate | 2 | 1998 | 288 | 0.010 |
Why?
|
Isomerases | 3 | 1991 | 4 | 0.010 |
Why?
|
Temperature | 2 | 1992 | 300 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 2 | 1992 | 427 | 0.010 |
Why?
|
beta-Lactams | 3 | 1984 | 11 | 0.010 |
Why?
|
Methanol | 1 | 1999 | 12 | 0.010 |
Why?
|
Biotransformation | 1 | 1999 | 20 | 0.010 |
Why?
|
Culture Media | 1 | 1999 | 77 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1990 | 111 | 0.010 |
Why?
|
Magnesium Sulfate | 1 | 1998 | 9 | 0.010 |
Why?
|
Ketoglutaric Acids | 1 | 1998 | 9 | 0.010 |
Why?
|
Dithiothreitol | 1 | 1998 | 18 | 0.010 |
Why?
|
Potassium Chloride | 1 | 1998 | 15 | 0.010 |
Why?
|
Ferrous Compounds | 1 | 1998 | 12 | 0.010 |
Why?
|
Colony Count, Microbial | 1 | 1998 | 57 | 0.010 |
Why?
|
Magnesium | 2 | 1992 | 58 | 0.010 |
Why?
|
Ascorbic Acid | 1 | 1998 | 52 | 0.010 |
Why?
|
Interphase | 1 | 1998 | 66 | 0.010 |
Why?
|
Ethanol | 1 | 1999 | 307 | 0.010 |
Why?
|
Phosphates | 2 | 1989 | 88 | 0.010 |
Why?
|
2-Aminoadipic Acid | 1 | 1992 | 1 | 0.010 |
Why?
|
Buffers | 1 | 1992 | 19 | 0.010 |
Why?
|
Valine | 1 | 1992 | 30 | 0.010 |
Why?
|
Enzyme Stability | 1 | 1992 | 46 | 0.010 |
Why?
|
Glutathione | 1 | 1992 | 51 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 1992 | 89 | 0.010 |
Why?
|
Time Factors | 1 | 1999 | 3567 | 0.010 |
Why?
|
Oxygenases | 1 | 1991 | 8 | 0.010 |
Why?
|
Chromatography, Affinity | 1 | 1991 | 48 | 0.010 |
Why?
|
Catalysis | 1 | 1992 | 154 | 0.010 |
Why?
|
Cysteine | 1 | 1992 | 107 | 0.010 |
Why?
|
Fetus | 1 | 1990 | 97 | 0.010 |
Why?
|
Penicillium chrysogenum | 1 | 1988 | 1 | 0.000 |
Why?
|
Iron | 1 | 1989 | 144 | 0.000 |
Why?
|
Fungal Proteins | 1 | 1988 | 142 | 0.000 |
Why?
|
Penicillinase | 1 | 1984 | 1 | 0.000 |
Why?
|
Ammonium Sulfate | 1 | 1984 | 1 | 0.000 |
Why?
|
Asparagine | 1 | 1984 | 24 | 0.000 |
Why?
|
Fermentation | 1 | 1984 | 36 | 0.000 |
Why?
|